Inhibidor da acetilcolinesterase (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Inhibidor da acetilcolinesterase" in Galician language version.

refsWebsite

Global rank Galician rank

19nih.gov

4^th place

6^th place

18doi.org

2^nd place

7^th place

2books.google.com

3^rd place

12^th place

2archive.org

6^th place

8^th place

2web.archive.org

1^st place

1england.nhs.uk

low place

1worldcat.org

5^th place

11^th place

1handle.net

102^nd place

163^rd place

1consumerreports.org

4,720^th place

low place

1mayoclinic.com

3,634^th place

3,250^th place

archive.org

Taylor D, Paton C, Shitij K (2012). Maudsley Prescribing Guidelines in Psychiatry (11th ed.). West Sussex: Wiley-Blackwell. ISBN 978-0-47-097948-8.
Karadsheh N, Kussie P, Linthicum DS (marzo de 1991). "Inhibition of acetylcholinesterase by caffeine, anabasine, methyl pyrrolidine and their derivatives". Toxicology Letters 55 (3): 335–42. PMID 2003276. doi:10.1016/0378-4274(91)90015-X.

books.google.com

O'Brien, Richard D. (2013-10-22). Toxic Phosphorus Esters: Chemistry, Metabolism, and Biological Effects (en inglés). Elsevier. ISBN 978-1-4832-7093-7.
Roberts, Stephen M.; James, Robert C.; Williams, Phillip L. (2014-12-08). Principles of Toxicology: Environmental and Industrial Applications (en inglés). John Wiley & Sons. ISBN 978-1-118-98248-8.

consumerreports.org

Consumer Reports; Drug Effectiveness Review Project (maio de 2012). "Evaluating Prescription Drugs Used to Treat: Alzheimer's Disease Comparing Effectiveness, Safety, and Price" (PDF). Best Buy Drugs: 2. Arquivado dende o orixinal (PDF) o 5 de setembro de 2012. Consultado o 1 de maio de 2013. , que aduce a directriz da Alzheimer's Association como fonte

doi.org

dx.doi.org

English, Brett A.; Webster, Andrew A. (2012). "Acetylcholinesterase and its Inhibitors". Primer on the Autonomic Nervous System. Elsevier. pp. 631–633. ISBN 978-0-12-386525-0. doi:10.1016/b978-0-12-386525-0.00132-3.
Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM (maio de 2013). "Acetylcholinesterase inhibitors: pharmacology and toxicology". Current Neuropharmacology (Bentham Science Publishers Ltd.) 11 (3): 315–35. PMC 3648782. PMID 24179466. doi:10.2174/1570159x11311030006.
McGleenon BM, Dynan KB, Passmore AP (outubro de 1999). "Acetylcholinesterase inhibitors in Alzheimer's disease". British Journal of Clinical Pharmacology 48 (4): 471–80. PMC 2014378. PMID 10583015. doi:10.1046/j.1365-2125.1999.00026.x.
Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM (maio de 2013). "Acetylcholinesterase inhibitors: pharmacology and toxicology". Current Neuropharmacology 11 (3): 315–35. PMC 3648782. PMID 24179466. doi:10.2174/1570159X11311030006.
Lotti M, Moretto A (2005-01-01). "Organophosphate-induced delayed polyneuropathy". Toxicological Reviews 24 (1): 37–49. PMID 16042503. doi:10.2165/00139709-200524010-00003.
Singh J, Kour K, Jayaram MB (xaneiro de 2012). "Acetylcholinesterase inhibitors for schizophrenia". The Cochrane Database of Systematic Reviews 1 (1): CD007967. PMC 6823258. PMID 22258978. doi:10.1002/14651858.CD007967.pub2.
Choi KH, Wykes T, Kurtz MM (setembro de 2013). "Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy". The British Journal of Psychiatry 203 (3): 172–8. PMC 3759029. PMID 23999481. doi:10.1192/bjp.bp.111.107359.
Ribeiz SR, Bassitt DP, Arrais JA, Avila R, Steffens DC, Bottino CM (abril de 2010). "Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature". CNS Drugs 24 (4): 303–17. PMID 20297855. doi:10.2165/11530260-000000000-00000.
Buckley AW, Sassower K, Rodriguez AJ, Jennison K, Wingert K, Buckley J, Thurm A, Sato S, Swedo S (agosto de 2011). "An open label trial of donepezil for enhancement of rapid eye movement sleep in young children with autism spectrum disorders". Journal of Child and Adolescent Psychopharmacology 21 (4): 353–7. PMC 3157749. PMID 21851192. doi:10.1089/cap.2010.0121.
Handen BL, Johnson CR, McAuliffe-Bellin S, Murray PJ, Hardan AY (febreiro de 2011). "Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures". Journal of Child and Adolescent Psychopharmacology 21 (1): 43–50. PMC 3037196. PMID 21309696. doi:10.1089/cap.2010.0024.
Chatonnet, Arnaud; Lenfant, Nicolas; Marchot, Pascale; Selkirk, Murray E. (2017-04-05). "Natural genomic amplification of cholinesterase genes in animals". Journal of Neurochemistry (International Society for Neurochemistry (Wiley)) 142: 73–81. ISSN 0022-3042. PMID 28382676. doi:10.1111/jnc.13990. hdl:10044/1/48129.
Karadsheh N, Kussie P, Linthicum DS (marzo de 1991). "Inhibition of acetylcholinesterase by caffeine, anabasine, methyl pyrrolidine and their derivatives". Toxicology Letters 55 (3): 335–42. PMID 2003276. doi:10.1016/0378-4274(91)90015-X.
Vladimir-Knežević S, Blažeković B, Kindl M, Vladić J, Lower-Nedza AD, Brantner AH (xaneiro de 2014). "Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the Lamiaceae family". Molecules 19 (1): 767–82. PMC 6271370. PMID 24413832. doi:10.3390/molecules19010767.
Miyazawa M, Yamafuji C (marzo de 2005). "Inhibition of acetylcholinesterase activity by bicyclic monoterpenoids". Journal of Agricultural and Food Chemistry 53 (5): 1765–8. PMID 15740071. doi:10.1021/jf040019b.
Perry NS, Houghton PJ, Theobald A, Jenner P, Perry EK (xullo de 2000). "In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes". The Journal of Pharmacy and Pharmacology 52 (7): 895–902. PMID 10933142. doi:10.1211/0022357001774598.
Wang BS, Wang H, Wei ZH, Song YY, Zhang L, Chen HZ (abril de 2009). "Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis". Journal of Neural Transmission 116 (4): 457–65. PMID 19221692. doi:10.1007/s00702-009-0189-x.
Rhee IK, Appels N, Hofte B, Karabatak B, Erkelens C, Stark LM, Flippin LA, Verpoorte R (novembro de 2004). "Isolation of the acetylcholinesterase inhibitor ungeremine from Nerine bowdenii by preparative HPLC coupled on-line to a flow assay system". Biological & Pharmaceutical Bulletin 27 (11): 1804–9. PMID 15516727. doi:10.1248/bpb.27.1804.
Messerer R, Dallanoce C, Matera C, Wehle S, Flammini L, Chirinda B, et al. (xuño de 2017). "Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2". MedChemComm 8 (6): 1346–1359. PMC 6072511. PMID 30108847. doi:10.1039/c7md00149e.

england.nhs.uk

"Medications for treating people with dementia" (PDF). Consultado o 1 de xaneiro de 2021.

handle.net

hdl.handle.net

Chatonnet, Arnaud; Lenfant, Nicolas; Marchot, Pascale; Selkirk, Murray E. (2017-04-05). "Natural genomic amplification of cholinesterase genes in animals". Journal of Neurochemistry (International Society for Neurochemistry (Wiley)) 142: 73–81. ISSN 0022-3042. PMID 28382676. doi:10.1111/jnc.13990. hdl:10044/1/48129.

mayoclinic.com

Bauer, Brent A. "Huperzine A: Can it treat Alzheimer's?". Mayo Clinic. Arquivado dende o orixinal o 2012-08-19.

nih.gov

ncbi.nlm.nih.gov

Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM (maio de 2013). "Acetylcholinesterase inhibitors: pharmacology and toxicology". Current Neuropharmacology (Bentham Science Publishers Ltd.) 11 (3): 315–35. PMC 3648782. PMID 24179466. doi:10.2174/1570159x11311030006.
McGleenon BM, Dynan KB, Passmore AP (outubro de 1999). "Acetylcholinesterase inhibitors in Alzheimer's disease". British Journal of Clinical Pharmacology 48 (4): 471–80. PMC 2014378. PMID 10583015. doi:10.1046/j.1365-2125.1999.00026.x.
Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM (maio de 2013). "Acetylcholinesterase inhibitors: pharmacology and toxicology". Current Neuropharmacology 11 (3): 315–35. PMC 3648782. PMID 24179466. doi:10.2174/1570159X11311030006.
Lotti M, Moretto A (2005-01-01). "Organophosphate-induced delayed polyneuropathy". Toxicological Reviews 24 (1): 37–49. PMID 16042503. doi:10.2165/00139709-200524010-00003.
Singh J, Kour K, Jayaram MB (xaneiro de 2012). "Acetylcholinesterase inhibitors for schizophrenia". The Cochrane Database of Systematic Reviews 1 (1): CD007967. PMC 6823258. PMID 22258978. doi:10.1002/14651858.CD007967.pub2.
Choi KH, Wykes T, Kurtz MM (setembro de 2013). "Adjunctive pharmacotherapy for cognitive deficits in schizophrenia: meta-analytical investigation of efficacy". The British Journal of Psychiatry 203 (3): 172–8. PMC 3759029. PMID 23999481. doi:10.1192/bjp.bp.111.107359.
Ribeiz SR, Bassitt DP, Arrais JA, Avila R, Steffens DC, Bottino CM (abril de 2010). "Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature". CNS Drugs 24 (4): 303–17. PMID 20297855. doi:10.2165/11530260-000000000-00000.
Buckley AW, Sassower K, Rodriguez AJ, Jennison K, Wingert K, Buckley J, Thurm A, Sato S, Swedo S (agosto de 2011). "An open label trial of donepezil for enhancement of rapid eye movement sleep in young children with autism spectrum disorders". Journal of Child and Adolescent Psychopharmacology 21 (4): 353–7. PMC 3157749. PMID 21851192. doi:10.1089/cap.2010.0121.
Handen BL, Johnson CR, McAuliffe-Bellin S, Murray PJ, Hardan AY (febreiro de 2011). "Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures". Journal of Child and Adolescent Psychopharmacology 21 (1): 43–50. PMC 3037196. PMID 21309696. doi:10.1089/cap.2010.0024.
Chatonnet, Arnaud; Lenfant, Nicolas; Marchot, Pascale; Selkirk, Murray E. (2017-04-05). "Natural genomic amplification of cholinesterase genes in animals". Journal of Neurochemistry (International Society for Neurochemistry (Wiley)) 142: 73–81. ISSN 0022-3042. PMID 28382676. doi:10.1111/jnc.13990. hdl:10044/1/48129.
Inglis F (xuño de 2002). "The tolerability and safety of cholinesterase inhibitors in the treatment of dementia". International Journal of Clinical Practice. Supplement (127): 45–63. PMID 12139367.
Singh, Ravneet; Sadiq, Nazia M. (2020). Cholinesterase Inhibitors. StatPearls (Treasure Island (FL): StatPearls Publishing). PMID 31335056. Consultado o 2020-10-12.
Karadsheh N, Kussie P, Linthicum DS (marzo de 1991). "Inhibition of acetylcholinesterase by caffeine, anabasine, methyl pyrrolidine and their derivatives". Toxicology Letters 55 (3): 335–42. PMID 2003276. doi:10.1016/0378-4274(91)90015-X.
Vladimir-Knežević S, Blažeković B, Kindl M, Vladić J, Lower-Nedza AD, Brantner AH (xaneiro de 2014). "Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the Lamiaceae family". Molecules 19 (1): 767–82. PMC 6271370. PMID 24413832. doi:10.3390/molecules19010767.
Miyazawa M, Yamafuji C (marzo de 2005). "Inhibition of acetylcholinesterase activity by bicyclic monoterpenoids". Journal of Agricultural and Food Chemistry 53 (5): 1765–8. PMID 15740071. doi:10.1021/jf040019b.
Perry NS, Houghton PJ, Theobald A, Jenner P, Perry EK (xullo de 2000). "In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes". The Journal of Pharmacy and Pharmacology 52 (7): 895–902. PMID 10933142. doi:10.1211/0022357001774598.
Wang BS, Wang H, Wei ZH, Song YY, Zhang L, Chen HZ (abril de 2009). "Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis". Journal of Neural Transmission 116 (4): 457–65. PMID 19221692. doi:10.1007/s00702-009-0189-x.
Rhee IK, Appels N, Hofte B, Karabatak B, Erkelens C, Stark LM, Flippin LA, Verpoorte R (novembro de 2004). "Isolation of the acetylcholinesterase inhibitor ungeremine from Nerine bowdenii by preparative HPLC coupled on-line to a flow assay system". Biological & Pharmaceutical Bulletin 27 (11): 1804–9. PMID 15516727. doi:10.1248/bpb.27.1804.
Messerer R, Dallanoce C, Matera C, Wehle S, Flammini L, Chirinda B, et al. (xuño de 2017). "Novel bipharmacophoric inhibitors of the cholinesterases with affinity to the muscarinic receptors M1 and M2". MedChemComm 8 (6): 1346–1359. PMC 6072511. PMID 30108847. doi:10.1039/c7md00149e.

web.archive.org

Consumer Reports; Drug Effectiveness Review Project (maio de 2012). "Evaluating Prescription Drugs Used to Treat: Alzheimer's Disease Comparing Effectiveness, Safety, and Price" (PDF). Best Buy Drugs: 2. Arquivado dende o orixinal (PDF) o 5 de setembro de 2012. Consultado o 1 de maio de 2013. , que aduce a directriz da Alzheimer's Association como fonte
Bauer, Brent A. "Huperzine A: Can it treat Alzheimer's?". Mayo Clinic. Arquivado dende o orixinal o 2012-08-19.

worldcat.org

Chatonnet, Arnaud; Lenfant, Nicolas; Marchot, Pascale; Selkirk, Murray E. (2017-04-05). "Natural genomic amplification of cholinesterase genes in animals". Journal of Neurochemistry (International Society for Neurochemistry (Wiley)) 142: 73–81. ISSN 0022-3042. PMID 28382676. doi:10.1111/jnc.13990. hdl:10044/1/48129.